Since hAM preparations strongly reduced the migration of cancer urothelial cells, we further investigated their effect on the expression of key components required for efficient cell migration, such as cortactin, RhoA, RhoC, Cdc42 and Rac1. The gene discussed is RAC1; the disease is cancer.